Payment overview · 2025
General Payments
$203.94
6 reported records · 3 companies
Healthcare provider profile · identity verified
James Jarvis
Allopathic & Osteopathic Physicians|Internal Medicine · PITTSBURGH, PA · NPI 1871567222
Verified facts
What the public records show
CMS Open Payments records show James Jarvis received $203.94 in general payments during 2025 across 6 reported records.
Novo Nordisk Inc accounted for 73.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 223 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $149.12 | 73.1% | 3 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $28.84 | 14.1% | 2 | 2025 |
| Inari Medical, Inc. | Unresolved — no canonical attribution shown | $25.98 | 12.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $203.94 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $114.30 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $34.82 | 2 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $28.84 | 2 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Inari Medical, Inc. | $25.98 | 1 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Inari Medical, Inc. | $25.98 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 223 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
223 | 30 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
25 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 656 | 160 |
| Lisinopril | Lisinopril | 476 | 114 |
| Amlodipine Besylate | Amlodipine Besylate | 474 | 107 |
| Levothyroxine Sodium | Levothyroxine Sodium | 386 | 79 |
| Gabapentin | Gabapentin | 362 | 61 |
| Omeprazole | Omeprazole | 329 | 79 |
| Losartan Potassium | Losartan Potassium | 324 | 69 |
| Simvastatin | Simvastatin | 324 | 68 |
| Eliquis | Apixaban | 321 | 61 |
| Oxycodone Hcl | Oxycodone Hcl | 314 | 48 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 310 | 85 |
| Pantoprazole Sodium | Pantoprazole Sodium | 298 | 81 |
| Furosemide | Furosemide | 236 | 55 |
| Metoprolol Succinate | Metoprolol Succinate | 228 | 56 |
| Sertraline Hcl | Sertraline Hcl | 228 | 44 |
| Famotidine | Famotidine | 226 | 52 |
| Ozempic | Semaglutide | 223 | 30 |
| Lorazepam | Lorazepam | 212 | 34 |
| Metoprolol Tartrate | Metoprolol Tartrate | 209 | 39 |
| Trazodone Hcl | Trazodone Hcl | 207 | 43 |
| Xarelto | Rivaroxaban | 207 | 22 |
| Fluticasone Propionate | Fluticasone Propionate | 206 | 62 |
| Hydrochlorothiazide | Hydrochlorothiazide | 197 | 57 |
| Tamsulosin Hcl | Tamsulosin Hcl | 197 | 59 |
| Carvedilol | Carvedilol | 192 | 37 |
| Prednisone | Prednisone | 183 | 55 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 181 | 33 |
| Escitalopram Oxalate | Escitalopram Oxalate | 172 | 29 |
| Metformin Hcl Er | Metformin Hcl | 161 | 51 |
| Tramadol Hcl | Tramadol Hcl | 158 | 30 |
| Potassium Chloride | Potassium Chloride | 156 | 23 |
| Celecoxib | Celecoxib | 152 | 48 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 140 | 48 |
| Alprazolam | Alprazolam | 139 | 41 |
| Mirtazapine | Mirtazapine | 139 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 137 | 23 |
| Meloxicam | Meloxicam | 131 | 32 |
| Metformin Hcl | Metformin Hcl | 129 | 40 |
| Clopidogrel | Clopidogrel Bisulfate | 126 | 31 |
| Levetiracetam | Levetiracetam | 120 | 12 |
| Atenolol | Atenolol | 115 | 25 |
| Allopurinol | Allopurinol | 113 | 24 |
| Risperidone | Risperidone | 106 | suppressed |
| Baclofen | Baclofen | 105 | 14 |
| Azithromycin | Azithromycin | 100 | 51 |
| Latanoprost | Latanoprost | 97 | 12 |
| Finasteride | Finasteride | 94 | 24 |
| Citalopram Hbr | Citalopram Hydrobromide | 93 | 22 |
| Ondansetron Hcl | Ondansetron Hcl | 90 | 25 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 87 | 20 |
| Pravastatin Sodium | Pravastatin Sodium | 86 | 24 |
| Hydrocortisone | Hydrocortisone | 84 | 15 |
| Spironolactone | Spironolactone | 84 | 23 |
| Pregabalin | Pregabalin | 82 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 79 | 23 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 76 | 18 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 75 | 46 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 75 | suppressed |
| Ibuprofen | Ibuprofen | 72 | 18 |
| Ipratropium Bromide | Ipratropium Bromide | 71 | 23 |
| Clonazepam | Clonazepam | 70 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 69 | 13 |
| Lactulose | Lactulose | 65 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 63 | 12 |
| Olanzapine | Olanzapine | 62 | suppressed |
| Jardiance | Empagliflozin | 61 | 15 |
| Montelukast Sodium | Montelukast Sodium | 59 | 18 |
| Breo Ellipta | Fluticasone/Vilanterol | 58 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 57 | 31 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 56 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 56 | 25 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 56 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 52 | 11 |
| Glipizide | Glipizide | 52 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 51 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 50 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 48 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 48 | 15 |
| Synthroid | Levothyroxine Sodium | 47 | 14 |
| Temazepam | Temazepam | 47 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 46 | 33 |
| Bupropion Xl | Bupropion Hcl | 46 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 46 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 44 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 43 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 43 | suppressed |
| Entresto | Sacubitril/Valsartan | 42 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 42 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 41 | 13 |
| Silodosin | Silodosin | 41 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 40 | 11 |
| Novolog Flexpen | Insulin Aspart | 40 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 39 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 37 | suppressed |
| Glimepiride | Glimepiride | 37 | 11 |
| Vancomycin Hcl | Vancomycin Hcl | 37 | suppressed |
| Octreotide Acetate | Octreotide Acetate | 35 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 35 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 34 | suppressed |
| Repaglinide | Repaglinide | 33 | suppressed |
| Cephalexin | Cephalexin | 32 | 24 |
| Valsartan | Valsartan | 32 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 31 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 31 | suppressed |
| Naproxen | Naproxen | 31 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 31 | suppressed |
| Trulicity | Dulaglutide | 31 | suppressed |
| Methadone Hcl | Methadone Hcl | 30 | suppressed |
| Diazepam | Diazepam | 29 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 29 | suppressed |
| Humulin R | Insulin Regular, Human | 29 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 29 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 29 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 28 | suppressed |
| Glipizide Er | Glipizide | 28 | suppressed |
| Methylprednisolone | Methylprednisolone | 28 | 23 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 28 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 27 | 12 |
| Diltiazem 24hr Er | Diltiazem Hcl | 27 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 27 | suppressed |
| Methocarbamol | Methocarbamol | 27 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 27 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 26 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 26 | suppressed |
| Amoxicillin | Amoxicillin | 26 | 21 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 26 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 26 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 25 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 25 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 25 | suppressed |
| Rybelsus | Semaglutide | 25 | suppressed |
| Brilinta | Ticagrelor | 24 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 24 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 24 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 23 | 20 |
| Ibu | Ibuprofen | 23 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 23 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 23 | suppressed |
| Roflumilast | Roflumilast | 23 | suppressed |
| Aripiprazole | Aripiprazole | 22 | suppressed |
| Fentanyl | Fentanyl | 22 | suppressed |
| Ketoconazole | Ketoconazole | 22 | suppressed |
| Bumetanide | Bumetanide | 21 | suppressed |
| Januvia | Sitagliptin Phosphate | 21 | suppressed |
| Metronidazole | Metronidazole | 21 | 12 |
| Valacyclovir | Valacyclovir Hcl | 21 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 20 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 20 | suppressed |
| Irbesartan | Irbesartan | 20 | suppressed |
| Lovastatin | Lovastatin | 20 | suppressed |
| Primidone | Primidone | 20 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 19 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | suppressed |
| Ezetimibe | Ezetimibe | 19 | suppressed |
| Humalog | Insulin Lispro | 19 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 19 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 19 | suppressed |
| Admelog | Insulin Lispro | 18 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 18 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 18 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 18 | 17 |
| Felodipine Er | Felodipine | 18 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 18 | suppressed |
| Myrbetriq | Mirabegron | 18 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 17 | suppressed |
| Creon | Lipase/Protease/Amylase | 17 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 17 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 16 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 16 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 16 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 15 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 15 | suppressed |
| Fluorometholone | Fluorometholone | 15 | suppressed |
| Insulin Lispro | Insulin Lispro | 15 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 15 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 14 | suppressed |
| Nystatin | Nystatin | 14 | 12 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 14 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 14 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 14 | suppressed |
| Genvoya | Elviteg/Cob/Emtri/Tenof Alafen | 13 | suppressed |
| Ramipril | Ramipril | 13 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 13 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Lamotrigine | Lamotrigine | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Methimazole | Methimazole | 12 | suppressed |
| Movantik | Naloxegol Oxalate | 12 | suppressed |
| Ondansetron Odt | Ondansetron | 12 | 11 |
| Perphenazine | Perphenazine | 12 | suppressed |
| Retacrit | Epoetin Alfa-Epbx | 12 | suppressed |
| Triumeq | Abacavir/Dolutegravir/Lamivudi | 12 | suppressed |
| Verapamil Sr | Verapamil Hcl | 12 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 11 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Memantine Hcl | Memantine Hcl | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $203.94 · 6 records | Novo Nordisk Inc | CT THROMBECTOMY SYSTEM KIT, Cologuard Collection Kit, FLOWTRIEVER CATHETER, S, Ozempic, Wegovy | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error